Oxular
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $51M
Investors
- 9
About Oxular
Founded in 2014 and based in the UK, Oxular Limited, formerly known as Precision Ocular is a retinal therapeutics company that develops technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs. Thomas Cavanagh is the co-founder and CEO of the company. In January 2024, Regeneron Pharmaceuticals, Inc., AMJ Capital, IP Group, NeoMed, Forbion, IP Group, Touchstone Innovations, N5 Capital, and V-Bio Ventures for an undisclosed amount. The company’s potent drug products provide significant pathophysiological pathways of retinal disease. The treatment durability safely provides up to 12-months of treatment effects from a single administration. The company utilizes its technology across its pipeline to develop treatments for retinal diseases, such as diabetic macular edema and macular degeneration, as well as programs for rare and orphan conditions, including ocular cancers and delivery of gene therapies.
Who invested in Oxular
9 investors across 5 rounds
See all investors in Oxular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oxular
Who invested in Oxular?
Oxular has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxular raised?
Oxular has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Oxular last raise money?
Oxular's most recent round on record is a Series A, in Feb 2021.
What does Oxular do?
Founded in 2014 and based in the UK, Oxular Limited, formerly known as Precision Ocular is a retinal therapeutics company that develops technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
Where is Oxular headquartered?
Oxular is headquartered in London, UK.
Which VCs invest in companies like Oxular?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Oxular's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oxular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.